Similar Papers

Paper Title
Journal
Date
Author
SELNET clinical practice guidelines for soft tissue sarcoma and GIST
...
Cancer Treatment Reviews | VOL. 102
, et. al. ...
14 Nov 2021
Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea-A Sarcoma-Specific, Institutional Registry-Based Analysis.
Hyehyun Jeong ... Jin-Hee Ahn
Cancer management and research | VOL. 13
Hyehyun Jeong, et. al.Hyehyun Jeong ... Jin-Hee Ahn
01 Nov 2021
Abstract B064: Racial disparities in bone and soft-tissue sarcomas: An analysis of the Surveillance, Epidemiology, and End Results program
Marc El Beaino ... Karim Masrouha
Cancer Epidemiology, Biomarkers & Prevention | VOL. 32
Marc El Beaino, et. al.Marc El Beaino ... Karim Masrouha
01 Dec 2023
When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma.
Ruben I Hack ... Beata Bode-Lesniewska
Life | VOL. 11
Ruben I Hack, et. al.Ruben I Hack ... Beata Bode-Lesniewska
24 Aug 2021
View more papers

More From: ESMO Open

Paper Title
Journal
Date
Author
Association between DNA damage repair alterations and outcomes to 177Lu-PSMA-617 in advanced prostate cancer.
A Rami ... P Ravi
ESMO open | VOL. 10
A Rami, et. al.A Rami ... P Ravi
22 Jan 2025
Treatment with infliximab and tacrolimus in steroid-refractory pneumonitis secondary to anti-HER2 therapy.
O Fakih ... C Palmieri
ESMO open | VOL. 10
O Fakih, et. al.O Fakih ... C Palmieri
22 Jan 2025
Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world.
E Blondeaux ... L Del Mastro
ESMO open | VOL. 10
E Blondeaux, et. al.E Blondeaux ... L Del Mastro
21 Jan 2025
Follow-up after first-Line nivOlumab plus ipilimumab in patients with diffuse pleuRal mesotheliomA: a real-world Dutch cohort study-FLORA.
L.H Douma ... C.J De Gooijer
ESMO open | VOL. 10
L.H Douma, et. al.L.H Douma ... C.J De Gooijer
21 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.